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Clinical Research Article
Background: For effective postoperative antiemetic management in pediatric moyamoya disease patients receiving 
fentanyl based postoperative analgesia, a multimodal approach has been recommended. The uncertain efficacy 
of ondansetron for pediatric neurosurgical patients or the possible antiemetic effect of small dose of propofol 
motivated us to evaluate the preventive effect of a subhypnotic dose of propofol combined with dexamethasone on 
postoperative vomiting (POV), especially during immediate postoperative periods.
Methods: In a prospective observer-blind randomized controlled study, we compared dexamethasone 0.15 mg/
kg alone (Group D) with dexamethasone combined with propofol of 0.5 mg/kg (Group DP) in 60 pediatric patients, 
aged 4-17 years, who underwent indirect bypass surgery and received fentanyl-based postoperative analgesia. 
Occurrence of vomiting and pain score (Wong-Baker facial score) and requirement of rescue analgesic and 
antiemetic were continually measured (0-2, 2-6, 6-12 and 12-24 postoperative hours). For statistical analysis, in 
addition to the Fisher’s exact test, a generalized linear mixed model (GLMM) and the linear mixed model (LMM) for 
repeated measures were used for vomiting and pain scores, respectively.
Results: There was no statistical significance of POV incidence, requirement of rescue analgesic and pain score 
between the two groups at any measured intervals. The incidence of POV was 53.3% during 24 hours in both groups, 
and was especially 6.7% and 13.3% (P = 0.671) during 0-2 hr and 16.7% and 23.3% (P = 0.748) during 2-6 hr in group 
D and group DP, respectively.
Conclusions: A small dose of propofol combined with dexamethasone appears ineffective to preventing POV in 
pediatric moyamoya patients receiving continuous fentanyl infusion. (Korean J Anesthesiol 2013; 64: 127-132)
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Introduction 
Moyamoya disease is a rare progressive ischemic vascular 
disorder predominantly in the territory of the anterior and 
middle cerebral arteries. Neovascularization procedures 
such as direct or indirect vascular bypass surgery are 
effectively practiced in most institutes for these patients, and 
intraoperative and postoperative management strategies are 
strictly based on hemodynamic stability and normocarbic 
status. According to the report by Hayash et al. [1], postoperative 
neurologic deterioration in moyamoya disease patients is often 
caused by cerebral hemodynamic changes such as a shift of the 
watershed area or hyperemia in brain regions. Both inadequate 
postoperative pain control and emesis activate the sympathetic 
nervous system and increase the intracranial pressure, and 
the postoperative care for pain and emesis can be very closely 
related to their morbidity and mortality of pediatric moyamoya 
patients [2,3]. Continuous intravenous infusion with fentanyl 
[4] was suggested to be effective for postoperative pain control 
in pediatric patients, but fentanyl also acts as a risk factor for 
postoperative nausea and vomiting (PONV) [5,6]. For high risk 
PONV patients, a multimodal approach is recommended [7] 
because most antiemetics work independently of each other 
and of the patient’s risk factor [8]. But the antiemetic effect of 
ondan setron is uncertain in pediatric neurosurgical patients [9-11]. 
It is widely believed that propofol based anesthesia reduces 
PONV more compared to volatile anesthesia [12]. Furthermore, 
even a small dose of propofol was reported to possess direct 
antiemetic effects [13-15], and an adjuvant subhypnotic 
dose [16,17] or infusion [18] of propofol to dexamethasone 
reduced emetic events in surgical or chemotherapy patients. 
For surgical patients, a small dose of propofol combined with 
dexamethasone was effective to preventing PONV during 
immediate postoperative periods without delaying anesthetic 
recovery [17] and would be valuable to neurosurgical patients.
Therefore, we compared the postoperative anti-vomiting effect 
between dexamethasone alone and dexamethasone with a small 
dose of propofol in pediatric moyamoya patients who under-
went encephalo-duro-arterio-synangiosis (EDAS) surgery and 
received continuous infusion of fentanyl for postoperative pain.
Materials and Methods
After approval of the Institutional Review Board and obtaining 
written informed consent from parents, this study was performed 
according to the declaration of Helsinki and 67 American Society 
of Anesthesiologists physical status I or II, diagnosed with 
moyamoya disease, aged 4-17 year of either sex, scheduled 
for EDAS surgery were enrolled during May 2009 and May 
2010 at a university hospital in this observer-blind prospective, 
randomized controlled study. Among them, 60 patients were 
included for data analysis according to our exclusion criteria; 
presence of neurologic signs or seizure at admission, history of 
motion sickness or PONV, mental retardation and requirement 
of postoperative ventilator care (Fig. 1). 
Patients fasted for 4-8 hours before surgery according to 
age. Premedication was not given. As patients arrived at the 
preinduction room with their parents, thiopental sodium 2 mg/
Fig. 1. Flow chart to track participants 
through randomized trial.
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kg was administered to children who were crying or anxious 
about entering the operating room. Anesthesia was induced with 
intravenous thiopental sodium 3-5 mg/kg followed by face mask 
ventilation with sevoflurane in air and oxygen. The trachea was 
intubated with the aid of rocuronium 0.7 mg/kg. Anesthesia was 
maintained with sevoflurane (2-4 vol%) in 50% oxygen and 
remifentanil infusion (0.1-0.4 μg/kg/min), and anesthetic depth 
was adjusted to changes in the hemodynamic variables within 
20% of baseline values. Controlled ventilation was adjusted to 
maintain end-tidal carbon dioxide partial pressure of 35-40 
mmHg. Body temperature was maintained within 36.0-36.7oC 
with air heater. Standard anesthetic monitors of ECG, invasive 
blood pressure, and pulse oximetry were applied continuously. 
For postoperative pain control, fentanyl i.v. infusion with a rate 
of 0.5 μg/kg/hr (with the maximum dose of 600 μg/day) began 
at dural closure and continued for 48 hours postoperatively. 
At the completion of surgery, residual muscle relaxation was 
completely reversed with neostigmine 0.02 mg/kg and atropine 
0.01 mg/kg after confirming the recovery of neuromuscular 
function using a nerve stimulator (TOF-Watch SX, Organon 
Ireland Limited, Dublin, Ireland). After completion of the head 
dressing, administration of remifentanil and sevoflurane was 
discontinued. The trachea was extubated by the attending 
anesthesiologist’s assessment that the patient regained 
spontaneous respiration adequately. Patients stayed in the 
postoperative care unit (PACU) for at least 1 hour, and were 
moved to a general ward.
Patients were randomly allocated into two groups with 
computer-generated random numbers. At dural closure, normal 
saline and dexamethasone 0.15 mg/kg (group D) or propofol 
0.5 mg/kg and dexamethasone 0.15 mg/kg (group DP) were 
administered. Nursing staffs in PACU and ward, who cared for 
the patients and knew of this clinical study but were blinded 
to the patient’s group, recorded every episode of vomiting for 
24 hours (at intervals of 0-2 hr, 2-6 hr, 6-12 hr and 12-24 
hr). Vomiting was defined as forced gastric and esophageal 
movement with either the expulsion of gastric contents or 
not. When vomiting occurred more than twice in 30 minutes 
or patients were intolerant to vomiting, metoclopramide 0.15 
mg/kg was administered as a rescue antiemetic. In addition, 
numeric scaled pain scores (0-5, Wong-Baker’s facial 
expression scale [4,19]) were evaluated. Ketorolac 1 mg/kg was 
intravenously administered as a rescue analgesic on the basis 
of the requirements of the children’s care giver or pain score of 
more than 3. 
Collected data included gender, age, weight, height, duration 
of anesthesia and operation, occurrence of postoperative 
vomiting (POV), pain severity, and number of patients who were 
administered with rescue antiemetic or analgesic. Recovery 
time (from discontinuation of anesthetics to awakening or eye 
opening with physical activities) was recorded.
Statistical analysis
We used the Student t-test and chi-square test or Fisher’s 
exact test for comparison of mean data and dichotomous data, 
respectively. For further analysis of the incidence of vomiting 
and pain score by the measuring time (0-2, 2-6, 6-12 and 
12-24 hr), we also used a generalized linear mixed model 
(GLMM) for repeated measure vomiting (applied with binomial 
response distribution and logit link function) and a linear mixed 
model (LMM) for a repeated pain measure score. A P value of 
less than 0.05 was considered significant. Statistical analysis was 
performed with Sigma stat v3.0 (Systat software, San Jose, Ca, 
USA) and a proc glimmix and proc mixed program (SAS 9.2 for 
Windows, SAS Institute Inc., Cary, NC, USA). 
Results
In comparison of demographic data between the two groups, 
Table 1. Demographic Data and Postoperative Rescue Medications
Group D (n = 30) Group DP (n = 30) P value
Sex (M/F)*
Age (yr)† 
Wt (kg)†
Ht (cm)†
Op. duration (min)†
Anes. duration (min)†
Recovery time (min)†
Postoperative analgesics/antiemetic
    Fentanyl consumption (μg/kg)†
    Rescue analgesic needed (no. of patients)‡
    Rescue antiemetic needed (no. of patients)‡
16/14
8.1 ± 3.4
27.3 ± 11.5
127.5 ± 21.4
119.3 ± 19.3
161.3 ± 23.3
14.3 ± 8.4
10.7 ± 2.6
14 (46.7%)
14 (46.7%)
13/17
10.0 ± 3.9
34.7 ± 15.9
133.7 ± 20.5
113.0 ± 26.9
165.1 ± 26.5
12.1 ± 10.5
11.1 ± 2.0 
  8 (26.7%)
13 (43.3%)
0.438
0.052
0.042
0.257
0.299
0.554
0.382
0.534
0.180
1.0
Data are mean ± SDM unless addressed. Statistical analyses were performed using *Chi-square test, †Student t-test, or ‡Fisher’s exact test. 
Group D and DP represent dexamethasone only treated- and dexamethasone and propofol treated- patients, respectively.
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patients of Group D weighed less than those of Group DP (27.3 
kg vs. 34.7 kg, P = 0.042). Otherwise, there were no differences 
between the two groups in demographic data. Recovery time 
from anesthesia, fentanyl consumption dose, and patient 
number who required rescue analgesic and antiemetic were not 
different between the two groups (Table 1). No patients showed 
oxygen desaturation of SpO2 < 90% during the recovery period 
and at PACU.
The Fisher’s exact test showed no difference of incidence of 
POV between two groups at any measured intervals with the 
overall incidence of POV of 53.3% in both groups during 24 
hours. GLMM analysis revealed that the incidence of vomiting 
during the postoperative 0-2 hr was lower than that during the 
6-12 hr (P < 0.05) as a factor of measured time regardless of 
group, but the interactive effect between groups and measured 
time was also insignificant (P > 0.05).
Postoperative pain scores during 0-2 and 2-6 hr were higher 
than those during 12-24 hr in both groups (P = 0.001) but did not 
differ between the two groups at measured intervals (Fig. 2).
Discussion
Our study failed to observe that adjuvant use of propofol 0.5 
mg/kg would increase the antiemetic effect of dexamethasone 
in pediatric moyamoya patients who underwent EDAS surgery 
under intraoperative use of sevoflurane and remifentanil and 
received fentanyl based postoperative analgesia.
Moyamoya disease is diagnosed with unique cerebral 
angio graphic findings frequently accompanied with transient 
ischemic attacks or seizures. The nature of this disease is 
progressive, and neovascularization procedures such as direct 
or indirect vascular bypass surgery prevent further aggravation 
and improve the occurrence of neurologic symptoms. Since 
the postoperative neurologic deterioration may be related with 
dynamic changes in bypassed vasculatures [1], postoperative 
care for adequate pain and PONV control is critically important. 
For high risk patients to PONV, multiple drug combinations 
with dexamethasone, dimenhydrinate, perphenazine, and 
serotonin type 3 receptor antagonists has been suggested to 
prevent postoperative emesis [20]. Nevertheless, ondansetron, 
a class of serotonin type 3 receptor antagonists, seems to be 
very effective in non-neurosurgical cases, it is still controversial 
for neurosurgical patients [9,11]. On the other hand, propofol 
was suggested as another candidate for drug combinations 
with dexamethasone to prevent postoperative emesis in 
some circumstances [16-18], especially during immediate 
postoperative periods rather than delayed periods. Therefore, 
we hypothesized that adjuvant use of propofol 0.5 mg/kg to 
prophylactic dexamethasone might reduce the incidence of 
POV further, especially during immediate postoperative periods, 
in pediatric moyamoya disease undergoing bypass surgery. This 
study must be the first report on the incidence of POV for them. 
The enrolled patients belong to a very high risk category of POV 
because of many well known risk factors or conditions; status 
as children, using sevoflurane and remifentanil in anesthetic 
maintenance, using fentanyl as postoperative analgesia, and 
undergoing craniotomy. The overall incidence of POV during 
24 hours in our moyamoya patients was 53.3% regardless of 
groups (Table 2) and was slightly lower than 66% of incidence 
Fig. 2. Postoperative Wong-Baker’s facial pain score. Data are 
presented as the mean and SDM. Statistical analysis with linear 
mixed model (LMM) revealed that pain scores at early postoperative 
periods (0-6 hr) were higher than those at 24 hr in both groups (*P = 
0.001) but did not differ between group D (black box, dexamethasone 
alone, n = 30) and group DP (white box, dexamethasone and pro-
pofol, n = 30) at any measured intervals. 
Table 2. Incidence and Odd Ratios of Postoperative Vomiting
Postoperative period
Vomiting
Group D (n = 30) Group DP (n = 30) P value* OR† (95% CI)
0-2 hr
2-6 hr
6-12 hr
12-24 hr
Overall
6.7% (1/1)
16.7% (2/3)
40.0% (5/7)
30.0% (4/5)
53.3% (9/7)
13.3% (3/1)
23.3% (3/4)
26.7% (5/3)
13.3% (2/2)
53.3% (7/9)
0.671
0.748
0.412
0.209
1.0
0.464 (0.078-2.751)
0.657 (0.183-2.363)
1.833 (0.616-5.453)
2.786 (0.751-10.331)
Data are % of patients (number of patients, male/female). *Fisher’s exact test with two sided analysis was performed. OR and CI refer to odd 
ratio and confidence interval, respectively. †OR presents the ratio of group D over group DP.
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in children undergoing craniotomy [11] probably due to less 
severe and shorter surgical procedures in spite of the fact 
that postoperative use of opioids would affect the incidence 
of POV in a dose-dependent manner [21]. We found similar 
requirements of rescue antiemetic and POV incidence at any 
measured intervals between the two groups with Fisher’s exact 
test. Contrary to previous studies which showed the antiemetic 
effect of a small dose of propofol combined with dexamethasone 
[16-18] in some clinical situations, our patients differ from them 
in some aspects; undergoing neurosurgery, being pediatric 
patients, and receiving fentanyl as postoperative analgesia. 
Even though that risk factors of postoperative emesis relating 
to surgical anesthesia and analgesia such as use of sevoflurane 
and remifentanil for anesthetic maintenance and fentanyl as 
postoperative analgesia would contribute independently to 
postoperative nausea and vomiting according to postoperative 
periods [5], it is uncertain whether small dose of propofol would 
potentiate the fentanyl induced vomiting during postoperative 
0-6 hours (Table 2) because propofol 0.5 mg/kg combined 
with dexamethasone 4 mg showed an antiemetic effect during 
postoperative 0-4 hours but not thereafter after middle ear 
surgery [17]. But in a later study, they compared propofol and 
dexamethasone with the placebo group and the patients were 
neurologically intact adults and had not received fentanyl 
as postoperative analgesia. With GLMM analysis, in spite of 
insignificant interaction effects between groups and the time 
factor, POV occurred less during early postoperative periods. 
Contrary to our expectations, there was rather a tendency for 
more patients of group DP than of group D vomited during 
the postoperative 0-6 hours and reversed thereafter (Table 2). 
It was hard to explain the reasons behind this postoperative 
vomiting tendency. Therefore, while seeking multi-antiemetic 
interventions should be maintained for high risk pediatric 
neurosurgical patients, the reduction of postoperative opioid 
doses by adding non-opioids such as non steroidal anti-
inflammatory agents [22] or by applying scalp nerve blocks [23] 
also needs to be considered.
Our study has some limitations. First, even though moya-
moya disease is uncommon, our sample size may be too small 
to completely exclude any beneficial effect of small doses of 
propofol . According to the incidence of POV during early 
postoperative periods (0-6 hours), a post-hoc power analysis 
showed 55% power to validate our results and a minimum of 25 
patients per group would be required to exclude the possible 
beneficial effect of propofol (Type II error). Therefore , this study 
may provide clinical significance as a pilot study. Second, we 
did not measure the plasma concentration of propofol to show 
the relationship between plasma concentration of propofol and 
its antiemetic effect because an antiemetic effect of propofol 
was shown at a plasma concentration of 343 ng/ml which was 
possible to reach with a bolus dose of 10 mg followed by an 
infusion of 10 mg/kg/min in adults [24]. In this study, the dose 
of propofol might be too small to achieve plasma concentration 
to show its antiemetic effect because the awakening time 
was not different between the two groups. But multimodal 
regimens with a higher bolus dose or infusion of propofol 
com bined with dexamethasome may not be appropriate 
because the antiemetic effect of subhypnotic propofol was 
associated with prolonged orientation time [15], Third, we did 
not measure the effect of propofol on nausea because it is not 
easy to measure the incidence of nausea in pediatric patients. 
Because the exact mechanisms of postoperative nausea and 
vomiting associated with separate risk factors are unclear and 
unrelated with each other, we could not exclude any favorable 
effect toward postoperative nausea in these patients. Forth, 
Lejus et al. [25] recently published three independent risk 
factors of POV (female, urological surgery and age of older 
than 3 years) in non-neurosurgical pediatric patients receiving 
continuous intravenous morphine. In this study, patients of 
Group D weighed less than those of Group DP (27.3 kg vs. 34.7 
kg, P = 0.042), perhaps due to a slightly younger group in D 
patients (8.1 yr vs. 10.0 yr, P = 0.052). However this would not 
influence the results. Even though there were no differences 
in sex distribution and mean age between the two groups in 
demographic data (Table 1) and similar sexual distribution at 
each measured interval between groups (Table 2) perhaps due 
to the small size of enrolled patients, we could not measure the 
exact impact of the sex distributions of ages over puberty in our 
results. 
In conclusion, the administration of small doses of propofol 
combined with dexamethasone during dural closure is not 
more effective than dexamethasone alone for the prevention of 
postoperative vomiting in pediatric moyamoya surgical patients 
receiving fentanyl as a postoperative analgesic. However further 
study with a large sample size may be needed.
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